Fennec Pharmaceuticals (FENC) Live Share Price, Invest From India

Fennec Pharmaceuticals Stock Performance

as on November 10, 2026 at 2:16 pm IST

Day's Low
Day's High
$9.94
Day's Price Range
$11.00
$10.83
8.22%
Downside
1.57%
Upside
52 Week's Low
52 Week's High
$5.65
52-Week Price Range
$13.25
$10.83
47.83%
Downside
22.35%
Upside

Fennec Pharmaceuticals share price movements today

Previous Close: $9.81
Open: $9.94
Volume: 285.8K
Market Cap: $344.0M
Day's Low - High: $9.94 - $11.00
52 Week Low - High: $5.65 - $13.25

Fennec Pharmaceuticals Historical Returns

1 Month Return: + 1.12 %
3 Month Return: -1.01 %
1 Year Return: + 41.02 %
3 Year Return: + 42.88 %
5 Year Return: + 16.7 %

Fennec Pharmaceuticals Stock Fundamentals & Key Indicators

Check Fennec Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$344.0M

EPS (TTM)

-0.13

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-75.46

Industry PE ratio

-9.28

PEG Ratio

-1.35

EBITDA

-2.4M

Revenue (TTM)

59.2M

Profit Margin

93.73%

Return On Equity TTM

-11.71%

Fennec Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Fennec Pharmaceuticals with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Fennec Pharmaceuticals	Buy	$344.0M	16.70%	-75.46	93.73%	0.00%
Moderna	Neutral	$101.5B	17.49%	-35.95	28.00%	0.00%
BeOne Medicines	StrongBuy	$46.5B	NA	66.55	88.39%	0.00%
Vertex Pharmaceuticals	StrongBuy	$138.7B	193.16%	34.94	85.57%	0.00%
Regeneron	Buy	$93.5B	47.86%	19.26	85.77%	0.41%

Stock Returns calculator for Fennec Pharmaceuticals Stock including INR - Dollar returns

The Fennec Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Fennec Pharmaceuticals investment value today

Current value as on today

₹1,49,315

Returns

₹49,315

(+49.31%)

Returns from Fennec Pharmaceuticals Stock

₹41,016 (+41.02%)

Dollar Impact

₹8,299 (+8.3%)

Analyst Recommendation on Fennec Pharmaceuticals Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Fennec Pharmaceuticals. Average target price of $17.2

Fennec Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Fennec Pharmaceuticals.

What analysts predicted

37.03%UPSIDE

Target Price

$17.2

Current Price

$10.83

Analyzed by

1 Analysts

High

$18

Target

$17.20

Low

$18

Fennec Pharmaceuticals target price $17.2, a slight upside of 37.03% compared to current price of $10.83. According to 1 analysts rating.

Indian Investors' Interest in Fennec Pharmaceuticals Stock

Search interest for Fennec Pharmaceuticals Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 11, 2026 to November 10, 2026

Change:-67% versus previous 30 day period

Fennec Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	25	7	6	7	8	9	12	13	15	17
Gross Profit	24	6	5	7	8	8	11	12	14	17
Operating Income	13	-5	-5	0	0	-2	0	-2	0	1
EBITDA	14	-4	-4	0	0	-2	0	-4	0	1
Interest Expense	1	1	1	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	12	-5	-5	-1	-1	-3	0	-4	0	2
Income Tax Expense	-	-	-	0	-	-	-	0	-	0
Net Income	12	-5	-5	-1	-1	-3	0	-4	0	1
Net Profit Margin	97.83%	91.63%	80.54%	91.56%	95.74%	89.98%	94.70%	87.20%	96.23%	95.97%

Fennec Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	0	-	1	21	47	44
Gross Profit	-	-	-	0	-	1	19	44	40
Operating Income	-6	-10	-13	-17	-17	-22	-13	2	-6
EBITDA	0	1	-13	-17	-17	-22	-12	4	-7
Interest Expense	-	-	-	-	0	0	3	4	2
Depreciation	6	10	-	0	0	0	0	0	0
Income Before Tax	-7	-9	-13	-18	-17	-23	-16	0	-9
Income Tax Expense	0	0	-	-	-	-	-	0	0
Net Income	-7	-9	-13	-18	-17	-23	-16	0	-9
Net Profit Margin	0.00%	0.00%	0.00%	100.00%	0.00%	94.40%	94.08%	93.30%	91.57%

Fennec Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	12	-5	-5	-1	-1	-3	0	-4	0	1
Operating Cash Flow	39	-8	-2	-1	-4	-3	1	-5	2	0
Investing Cash Flow	-	-	-	-	-	-	-	-	-	-
Financing Cash Flow	-1	0	0	-12	0	0	1	20	1	1
Change in Cash	37	-8	-2	-13	-3	-3	3	14	3	1

Fennec Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-7	-9	-12	-18	-17	-23	-16	0	-10
Operating Cash Flow	-3	-7	-9	-15	-14	-18	-17	26	-12
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	27	2	0	32	4	20	6	-13	22
Change in Cash	24	-5	-9	16	-9	2	-10	13	10

Global Institutional Holdings in Fennec Pharmaceuticals

Check out the Institutions with significant holdings in Fennec Pharmaceuticals.

Funds	Holdings
Southpoint Capital Advisors Lp	7.83%
iShares	3.22%
Vanguard	2.90%
VANGUARD INDEX FUNDS	2.32%
Fidelity Salem Street Trust	0.98%

See all

Insights on Fennec Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, FENC stock has moved up by 56.3%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 284.0% return, outperforming this stock by 241.1%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 986.4% return, outperforming this stock by 945.4%

About Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.

Organisation	Fennec Pharmaceuticals
Headquarters	68 TW Alexander Drive, Research Triangle Park, NC, 27709, US
Industry	Biotechnology
CEO	Jeffrey S. Hackman

Key Management of Fennec Pharmaceuticals

Name	Title
Ms. Christiana Cioffi M.B.A.	Chief Strategy Officer
Mr. Mark Gowland	Controller
Mr. Lei Fang	President of Pharstat Inc
Mr. Jeffrey S. Hackman	CEO & Director
Mr. Robert C. Andrade	Chief Financial Officer
Dr. Pierre S. Sayad M.S., Ph.D.	Chief Medical Officer
Mr. Terry Evans	Chief Commercial Officer

FAQs

What is Fennec Pharmaceuticals share price today?

Fennec Pharmaceuticals share price today is $10.83 as on November 10, 2026 at 8:46 am IST at the close of the market. Fennec Pharmaceuticals share today touched a day high of $11.00 and a low of $9.94.

What is the 52 week high and 52 week low for Fennec Pharmaceuticals share?

Fennec Pharmaceuticals share touched a 52 week high of $13.25 on August 12, 2026 and a 52 week low of $5.65 on April 13, 2026. Fennec Pharmaceuticals stock price today i.e. November 10, 2026 at 8:46 am IST is closed at $10.83,which is 18.26% down from its 52 week high and 91.68% up from its 52 week low.

What is Fennec Pharmaceuticals's market capitalisation today?

Fennec Pharmaceuticals market capitalisation is $0.00T as on November 10, 2026 at 8:46 am IST.

How to invest in Fennec Pharmaceuticals Stock (FENC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Fennec Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Fennec Pharmaceuticals Stock (FENC) from India?

Indian investors can start investing in Fennec Pharmaceuticals (FENC) shares with as little as ₹93.92749786376953 or $1 (as of November 10, 2026 at 11:08 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹939.27 in Fennec Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on November 10, 2026 at 11:08 am IST). Based on Fennec Pharmaceuticals share’s latest price of $10.83 as on November 10, 2026 at 8:46 am IST, you will get 0.9234 shares of Fennec Pharmaceuticals. Learn more about fractional shares .

What are the returns that Fennec Pharmaceuticals has given to Indian investors in the last 5 years?

Fennec Pharmaceuticals stock has given 16.7% share price returns and 26.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?